Monograph Details

Urogenital System > Overactive bladder/enuresis
DITROPAN SYRUP
Manufacturer
Ortho-McNeil Pharmaceuticals, Inc.
Legal Classification
Rx
Pharmacological Class
Antispasmodic/anticholinergic.
Generic Name
Oxybutynin chloride 5mg/5mL.
Also
DITROPAN
Indications
Symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (eg, urinary urgency, frequency, leakage, urge incontinence, dysuria).
Children
<5yrs: not recommended. ≥5yrs: 5mg twice daily; max 15mg/day.
Adults
5mg 2–3 times a day; max 20mg/day.
Contraindications
Uncontrolled glaucoma. GI obstruction. Paralytic ileus. Intestinal atony in elderly or debilitated. Severe colitis. Myasthenia gravis. Megacolon. Toxic megacolon in ulcerative colitis. Obstructive uropathies. Unstable cardiovascular status in acute hemorrhage.
Precautions
Activities requiring mental alertness. Diarrhea. Hepatic or renal disease. Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease. Hiatal hernia. GI or GU obstruction. Ulcerative colitis. Exposure to extreme heat. Elderly. Pregnancy (Cat.B). Nursing mothers.
Interactions
Potentiates drowsiness with alcohol, other CNS depressants. Additive anticholinergic effects with other anticholinergics. May be potentiated by CYP3A4 inhibitors. Decreases GI motility, possibly affecting absorption of other drugs.
Adverse Reactions
Dry mouth, constipation, somnolence, headache, diarrhea, nausea, tachycardia, blurred vision, dry eyes, other anticholinergic effects.
How Supplied
Tabs—100, 1000
Syrup—pt
Additional Resources
Related Prescribing Note